AKBA · Akebia Therapeutics, Inc. · Fails to Deliver
$0.42
+0.01 (+3.28%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$117.26M
Shares
277.66M
Volume · Nov 19
2.75M
Avg daily vol (3M)
8.17M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-30 | 1,314 | $0.74 | $972 |
| 2026-10-29 | 43,702 | $0.76 | $33,214 |
| 2026-10-28 | 1,314 | $0.66 | $867 |
| 2026-10-27 | 1,314 | $0.64 | $841 |
| 2026-10-26 | 1,314 | $0.57 | $749 |
| 2026-10-23 | 1,314 | $0.56 | $736 |
| 2026-10-22 | 187,247 | $0.59 | $110,476 |
| 2026-10-21 | 1,314 | $0.62 | $815 |
| 2026-10-20 | 99,427 | $0.68 | $67,610 |
| 2026-10-19 | 1,314 | $0.67 | $880 |
| 2026-10-16 | 1,314 | $0.70 | $920 |
| 2026-10-15 | 1,314 | $0.70 | $920 |
| 2026-10-14 | 1,314 | $0.77 | $1,012 |
| 2026-10-13 | 1,314 | $0.79 | $1,038 |
| 2026-10-09 | 94,802 | $0.81 | $76,790 |
| 2026-10-08 | 14,675 | $0.87 | $12,767 |
| 2026-10-07 | 1,314 | $0.88 | $1,156 |
| 2026-10-06 | 1,314 | $0.91 | $1,196 |
| 2026-10-05 | 1,314 | $0.87 | $1,143 |
| 2026-10-02 | 1,314 | $0.87 | $1,143 |
| 2026-10-01 | 24,695 | $0.92 | $22,719 |
| 2026-09-30 | 1,314 | $0.89 | $1,169 |
| 2026-09-29 | 1,314 | $0.89 | $1,169 |
| 2026-09-28 | 1,314 | $0.90 | $1,183 |
| 2026-09-25 | 1,314 | $0.92 | $1,209 |
| 2026-09-24 | 1,314 | $0.93 | $1,222 |
| 2026-09-23 | 1,949 | $0.98 | $1,910 |
| 2026-09-22 | 1,314 | $0.94 | $1,235 |
| 2026-09-21 | 1,314 | $0.92 | $1,209 |
| 2026-09-18 | 151,739 | $0.90 | $136,565 |
| 2026-09-17 | 1,314 | $0.92 | $1,209 |
| 2026-09-16 | 1,314 | $0.90 | $1,183 |
| 2026-09-15 | 1,314 | $0.96 | $1,261 |
| 2026-09-14 | 1,314 | $0.95 | $1,248 |
| 2026-09-11 | 12,183 | $0.95 | $11,574 |
| 2026-09-10 | 3,707 | $0.95 | $3,522 |
| 2026-09-09 | 1,314 | $1.03 | $1,353 |
| 2026-09-08 | 1,314 | $0.97 | $1,275 |
| 2026-09-04 | 1,314 | $0.98 | $1,288 |
| 2026-09-03 | 1,314 | $0.98 | $1,288 |
| 2026-09-02 | 1,314 | $0.94 | $1,235 |
| 2026-09-01 | 2,009 | $0.92 | $1,848 |
| 2026-08-31 | 1,314 | $0.88 | $1,156 |
| 2026-08-28 | 2,798 | $0.94 | $2,630 |
| 2026-08-27 | 1,314 | $0.91 | $1,196 |
| 2026-08-26 | 132,627 | $0.96 | $127,322 |
| 2026-08-25 | 1,517 | $0.90 | $1,365 |
| 2026-08-24 | 1,517 | $0.91 | $1,380 |
| 2026-08-21 | 1,879 | $0.92 | $1,729 |
| 2026-08-20 | 1,517 | $0.89 | $1,350 |
Showing 1–50 of 50 settlements
Key facts
CIK
1517022
CUSIP
00972D105
13F (30d)
157 filings
140 filers
Visit website
Investor relations